Media Alert For 2021 Global Science Summit On COVID-19
To register for the event, click here: https://www.covidsciencesummit.com.
You will receive an email with a webcast link prior to the start of the event.
Attendees are invited to submit questions for panelists prior to the event at https://www.covidsciencesummit.com.
The 2021 Global Science Summit on COVID-19 is being hosted by
The event will focus on the most up-to-date science amassed from the past year of studying COVID-19, including how best to address the many ongoing questions about how the virus will affect society, travel and day-to-day activities moving forward. The Summit will feature world-renowned medical, epidemiological and public health experts to explore and share recent findings and daily practices to curb the spread of COVID-19 in a post-pandemic future.
Panels will include fact-based discussions sharing the latest insights on epidemiology, screening, testing and tracing, therapeutics, vaccines, practical prevention and mitigation practices and more, including:
- The Science of COVID-19: Epidemiology; Transmission; Testing.
- Treatment & Prevention: Masks, Surfaces and Physical Distancing; Isolation and Quarantine; Vaccines; Therapeutics.
- Life in a World with COVID-19: Practicality; Adapting; Risk Mitigation.
The event is designed for the general public, and it is free to attend all or parts of the discussion. Registration is now open at https://www.covidsciencesummit.com.
The virtual Summit is hosted by
Arnold Donald, president & CEO, Carnival Corporation Gloria Guevara, president & CEO, WTTC
Donald and Guevara will encourage straightforward, easy-to-understand and fact-based discussions sharing the latest insights on epidemiology, screening, testing and tracing, therapeutics, vaccines, practical prevention and mitigation practices and more. Panelists include (in alphabetical order):
Michael Diamond, M.D., Ph.D., the Herbert S. Gasser Professor of Medicine at Washington University. Dr. Diamond is recognized internationally for his work involving Zika, West Nile, chikungunya, and related emerging viruses.
Steven Gordon, M.D., chairman, department of infectious disease, Cleveland Clinic, Respiratory Instituteand professor of medicine, The Lerner College of Medicine, Case Western University. Dr. Gordonhas been focused on hospital infection prevention, including device-associated and opportunistic infections in immunocompromised patients.
Michael Lin, M.D., Ph.D. is Associate Professor of Neurobiology, Bioengineering, and Chemical and Systems Biology at Stanford University. A NIH Pioneer Award recipient, Dr. Lindevelops protein-based tools for molecular imaging and control of gene and viral therapy.
William Morice, II, M.D., Ph.D., chair, department of laboratory medicine and pathology at Mayo Clinic, president, Mayo Clinic Laboratories, and professor of laboratory medicine and pathology. Dr. Moriceis an expert in diagnostic testing serving in leadership roles for numerous boards and partnerships to enhance understanding of clinical diagnostics and test utilization.
Jewel Mullen, M.D., M.P.H., associate dean for health equity, University of Texas at Austin, Dell Medical School. Dr. Mullenis an internist, epidemiologist and public health physician leader and the former principal deputy assistant secretary for health in the U.S. Department of Health and Human Services(HHS).
Emil Christian Reisinger, director of the Department of Tropical Medicine and Infectious Diseasesat the Department of Internal Medicineat the University of Rostock, Dean of the University and Member of the Board of the University Hospital Rostock.
Clare Rock, M.D., M.S., Associate Professor of Medicine, Associate Hospital Epidemiologist, Johns Hopkins University School of Medicine. Dr. Rockhas significant expertise in institutional COVID-19 support, including as Hospital Epidemiology and Infection Control COVID-19 Johns Hopkins Health System Incident Commander. Specific expertise and experience include COVID-19 testing strategies for the workplace, businesses, & community, return to work policies, return to business strategies, outbreak and cluster management, contact tracing, addressing COVID-19 vaccine hesitancy in the workplace and the community.
Stefano Vella, Adjunct Professor of Global Health at the Catholic Universityof Romeand a member of the Program Committee of Horizon Europe- Health Cluster, the Research Program of the European Commission. Dr. Vellaspecializes in infectious diseases and internal medicine and is a researcher in pathogenesis and therapy of viral infections. Specific research has been conducted by Dr. Vellaon major pandemics, specifically on HIV/AIDS and Tuberculosis.
Register for the event at: https://www.covidsciencesummit.com.
World Travel & Tourism Council (WTTC) Press Office | email@example.com; Roger Frizzell | firstname.lastname@example.org | (305) 406-7862; Mike Flanagan | email@example.com | (727) 452-4538